Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Details Narrative)

v3.25.1
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Nov. 26, 2024
Oct. 03, 2022
Jul. 23, 2021
Defined Benefit Plan Disclosure [Line Items]            
Outstanding warrants to purchase an aggregate shares     56,237      
Director [Member]            
Defined Benefit Plan Disclosure [Line Items]            
Shares remaining available for grant 156,592          
Twin Vee [Member]            
Defined Benefit Plan Disclosure [Line Items]            
Stock based compensation expense $ 55,968 $ 426,283        
Dividend yield 0.00%          
Options unvested 81,675          
Twin Vee [Member] | Common Stock Warrants [Member]            
Defined Benefit Plan Disclosure [Line Items]            
Warrants activity 0          
Twin Vee [Member] | Common Stock Warrants [Member] | Underwriters [Member]            
Defined Benefit Plan Disclosure [Line Items]            
Warrants outstanding       10,550 14,375 15,000
Warrants weighted-average exercise       $ 102.20 $ 34.38 $ 75.00
Expire date       August 11, 2027 September 28, 2027 July 20, 2026
Twin Vee [Member] | Common Stock Warrants One [Member] | Underwriters [Member]            
Defined Benefit Plan Disclosure [Line Items]            
Warrants outstanding       16,312    
Warrants weighted-average exercise       $ 30.70    
Expire date       June 12, 2028